Iambic Therapeutics, founded in 2019 and based in San Diego, California, is revolutionizing the field of therapeutics through its cutting-edge AI-driven drug-discovery platform. The company is comprised of a dynamic team of AI specialists and seasoned drug hunters, all united in their mission to deliver clinically validated therapeutics with remarkable efficiency across a diverse range of target classes and mechanisms of action. Iambic's innovative approach has successfully propelled a pipeline of clinical assets designed to meet pressing patient needs, showcasing the effectiveness of its platform. With a strong commitment to inclusivity, Iambic cultivates a collaborative workplace that celebrates diversity in background and experience, ensuring a rich environment for innovation and growth.